Children younger than 15 may be given 2 HPV vaccine doses instead of 3, and the shots should be spaced at least 6 months apart.
A new HPV screening test that uses cervical cells collected for a Pap test has been approved by the FDA.
A greater understanding of the healthcare issues specific to the lesbian, gay, bisexual, and transgender community may improve the quality of care.
College-aged students may benefit from continued education regarding the spread of HPV, especially oral transmission
The new vaccine protects against 9 types of HPV and 5 cancer-causing strains.
The American Society of Clinical Oncology has released its recommendations to help improve rates of HPV vaccination worldwide.
Data collected between 2009 and 2012 show a significant decline in cases of HPV in females aged 14-19 and 20-24.
Confusion surrounds the current screening recommendations and guidelines.
A variety of factors have led to low rates of teenage boys being vaccinated for the human papillomavirus (HPV), said a report published in Pediatrics.
Human papillomavirus vaccination not linked to increase in sexually transmitted infections in adolescent femalesOctober 02, 2015
The HPV vaccination is not associated with an increase in sexually transmitted infections in adolescent females, study results suggest. The vaccine is recommended for all children 11 to 12 years old.
The Cervarix vaccine may be as effective in one or two doses as it is with three.
In survey, more than half didn't get vaccinated; many were unaware of risk
While not statistically significant, participants who noted they had received the HPV vaccine also reported that they used condoms without fail at every sexual encounter.
The potential costs and effectiveness of HPV4 vaccination versus no vaccination were compared in a theoretical cohort based on a cohort of 192,940 boys aged 12 years.
The CDC's Advisory Committee on Immunization Practices met to vote on updates to several vaccine recommendations, including for HPV.
Almost half of American girls receive the HPV vaccine after the recommended age.
In a survey conducted by the Advisory Committee on Immunization Practices (ACIP), 33% of clinicians routinely recommend the HPV4 vaccine to 11- and 12-year-old males.
The cobas HPV test detects DNA from 14 types of HPV and included types 16 and 18, which cause 70% of cervical cancers.
In primary and secondary analyses, vaccination was not associated with an increased risk of multiple sclerosis or other demyelinating diseases.
Having female sex partner with HPV puts men at greater risk for contracting HPV type responsible for throat cancers.
One third of women aged 15 to 26 years with precancerous cervical lesions were infected with more than one type of HPV.
After surveying low-income communities, researchers found that human papillomavirus knowledge did not sway vaccination compliance.
Vaccination-induced anti-HPV response persists through 96 months for all HPV vaccine types.
1/3 of parents of girls reported that their child's clinician had failed to recommended the HPV vaccination during office visits.
As human papilloma virus-associated oropharyngeal cancers become more prevalent, clinicians should discuss risks with patients.
Test specifically identifies HPV types 16 and 18, as well as detecting 12 other types of high-risk HPVs.
New HPV test could be used before or instead of Pap test for cervical cancer screening.
Make sure parents understand utility of the HPV vaccine for preventing cancer, not just sexually transmitted diseases.
Efforts to improve HPV vaccine uptake in boys should focus on parent education, link between virus and cancer.
Cancers of the base of the tongue, the tonsils, the soft palate and the pharynx have increased 60% in those younger than age 45 years since the 1970s.